53 results on '"Hall, W. Jackson"'
Search Results
2. Brain Natriuretic Peptide and Cardiac Resynchronization Therapy in Patients With Mildly Symptomatic Heart Failure
3. Survival of Patients Receiving a Primary Prevention Implantable Cardioverter-Defibrillator in Clinical Practice vs Clinical Trials
4. Reduction in Inappropriate Therapy and Mortality through ICD Programming
5. Cardiac Resynchronization and Quality of Life in Patients With Minimally Symptomatic Heart Failure
6. Effect of Cardiac Resynchronization Therapy on the Risk of First and Recurrent Ventricular Tachyarrhythmic Events in MADIT-CRT
7. Reduction in Life-Threatening Ventricular Tachyarrhythmias in Statin-Treated Patients With Nonischemic Cardiomyopathy Enrolled in the MADIT-CRT (Multicenter Automatic Defibrillator Implantation Trial with Cardiac Resynchronization Therapy)
8. Multicenter Automatic Defibrillator Implantation Trial: Reduce Inappropriate Therapy (MADIT-RIT): Background, Rationale, and Clinical Protocol
9. Response to Letter Regarding Article, “Predictors of Response to Cardiac Resynchronization Therapy in The Multicenter Automatic Defibrillator Implantation Trial With Cardiac Resynchronization Therapy (MADIT-CRT)”
10. Predictors of Response to Cardiac Resynchronization Therapy in the Multicenter Automatic Defibrillator Implantation Trial With Cardiac Resynchronization Therapy (MADIT-CRT)
11. Reduction of the Risk of Recurring Heart Failure Events With Cardiac Resynchronization Therapy
12. Risk of Recurrent Cardiac Events After Onset of Menopause in Women With Congenital Long-QT Syndrome Types 1 and 2
13. Effectiveness of Cardiac Resynchronization Therapy by QRS Morphology in the Multicenter Automatic Defibrillator Implantation Trial–Cardiac Resynchronization Therapy (MADIT-CRT)
14. Cardiac Resynchronization Therapy Is More Effective in Women Than in Men
15. Time dependence of life-threatening ventricular tachyarrhythmias after coronary revascularization in MADIT-CRT
16. Effect of Cardiac Resynchronization Therapy on Reverse Remodeling and Relation to Outcome
17. Cardiac-Resynchronization Therapy for the Prevention of Heart-Failure Events
18. Predictors of long-term mortality in Multicenter Automatic Defibrillator Implantation Trial II (MADIT II) patients with implantable cardioverter-defibrillators
19. Reply
20. Risk of death in the long QT syndrome when a sibling has died
21. Inappropriate Implantable Cardioverter-Defibrillator Shocks in MADIT II
22. Risk Stratification for Primary Implantation of a Cardioverter-Defibrillator in Patients With Ischemic Left Ventricular Dysfunction
23. Ventricular arrhythmia storms in postinfarction patients with implantable defibrillators for primary prevention indications: A MADIT-II substudy
24. Health-Related Quality of Life Consequences of Implantable Cardioverter Defibrillators
25. Inverse Relationship of Blood Pressure Levels to Sudden Cardiac Mortality and Benefit of the Implantable Cardioverter-Defibrillator in Patients With Ischemic Left Ventricular Dysfunction
26. Prognostic Value of Location and Type of Myocardial Infarction in the Setting of Advanced Left Ventricular Dysfunction
27. Long QT Syndrome in Adults
28. Causes and Consequences of Heart Failure After Prophylactic Implantation of a Defibrillator in the Multicenter Automatic Defibrillator Implantation Trial II
29. The Cost Effectiveness of Implantable Cardioverter-Defibrillators
30. Time Dependence of Defibrillator Benefit After Coronary Revascularization in the Multicenter Automatic Defibrillator Implantation Trial (MADIT)-II
31. Reduction in Ventricular Tachyarrhythmias With Statins in the Multicenter Automatic Defibrillator Implantation Trial (MADIT)-II
32. Predictive Value of Ventricular Arrhythmia Inducibility for Subsequent Ventricular Tachycardia or Ventricular Fibrillation in Multicenter Automatic Defibrillator Implantation Trial (MADIT) II Patients
33. Factors Influencing Appropriate Firing of the Implanted Defibrillator for Ventricular Tachycardia/Fibrillation
34. Safety and Efficacy of Flecainide in Subjects with Long QT-3 Syndrome (DeltaKPQ Mutation): A Randomized, Double-Blind, Placebo-Controlled Clinical Trial
35. Multicenter Automatic Defibrillator Implantation Trial–Cardiac Resynchronization Therapy (MADIT‐CRT): Design and Clinical Protocol
36. Effects of Beta-Blockers on Implantable Cardioverter Defibrillator Therapy and Survival in the Patients with Ischemic Cardiomyopathy (from the Multicenter Automatic Defibrillator Implantation Trial-II)
37. Comparison of Efficacy of Implanted Cardioverter-Defibrillator in Patients With Versus Without Diabetes Mellitus
38. Long-Term Clinical Course of Patients After Termination of Ventricular Tachyarrhythmia by an Implanted Defibrillator
39. Time Dependence of Mortality Risk and Defibrillator Benefit After Myocardial Infarction
40. Prophylactic Implantation of a Defibrillator in Patients with Myocardial Infarction and Reduced Ejection Fraction
41. Increased Risk of Arrhythmic Events in Long-QT Syndrome With Mutations in the Pore Region of the Human Ether-a-go-go–Related Gene Potassium Channel
42. Clinical Implications for Affected Parents and Siblings of Probands With Long-QT Syndrome
43. Effectiveness and Limitations of β-Blocker Therapy in Congenital Long-QT Syndrome
44. Ovarian Cancer: Comparison of Observer Performance for Four Methods of Interpreting CT Scans
45. Influence of the Genotype on the Clinical Course of the Long-QT Syndrome
46. Age- and Sex-Related Differences in Clinical Manifestations in Patients With Congenital Long-QT Syndrome
47. The Cost-effectiveness of Automatic Implantable Cardiac Defibrillators
48. Influence of Pregnancy on the Risk for Cardiac Events in Patients With Hereditary Long QT Syndrome
49. Improved Survival with an Implanted Defibrillator in Patients with Coronary Disease at High Risk for Ventricular Arrhythmia
50. Marked reduction in long-term cardiac deaths with aspirin after a coronary event
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.